(Q46277042)

21 December 2017

title

Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum (English)

1 reference

21 December 2017

0 references

0 references

Eshwar Mahenthiralingam

6

1 reference

21 December 2017

David W. Denning

7

1 reference

21 December 2017

Riina Rautemaa

object named as

Riina Rautemaa

2

0 references

Andrew M Jones

object named as

Andrew M Jones

3

0 references

author name string

Caroline G Baxter

1

1 reference

21 December 2017

A Kevin Webb

4

1 reference

21 December 2017

Matthew Bull

5

1 reference

21 December 2017

language of work or name

English

0 references

publication date

19 March 2013

1 reference

21 December 2017

published in

Thorax

1 reference

21 December 2017

volume

68

1 reference

21 December 2017

issue

7

1 reference

21 December 2017

page(s)

652-657

1 reference

21 December 2017

Comparison of techniques to examine the diversity of fungi in adult patients with cystic fibrosis

cites work

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202412

Detection and accurate identification of new or emerging bacteria in cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202412

Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202412

Aspergillus fumigatus biofilms in the clinical setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202412

Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202412

Pseudomonas aeruginosa and their small diffusible extracellular molecules inhibit Aspergillus fumigatus biofilm formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202412

Risk factors for Aspergillus colonization and allergic bronchopulmonary aspergillosis in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202412

Significance of the microbiome in obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202412

Microbial ecology of the cystic fibrosis lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202412

Standardisation of spirometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202412

Culture-independent analysis of bacterial fuel contamination provides insight into the level of concordance with the standard industry practice of aerobic cultivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202412

Evaluation of analytical and preliminary clinical performance of Myconostica MycAssay Aspergillus when testing serum specimens for diagnosis of invasive Aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202412

Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202412

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202412

Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202412

Macrolides decrease the minimal inhibitory concentration of anti-pseudomonal agents against Pseudomonas aeruginosa from cystic fibrosis patients in biofilm

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202412

Investigations on anti-Aspergillus properties of bacterial products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202412

The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1->3) β-d-glucan and consequences of delayed antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202412

False-positive serum and bronchoalveolar lavage Aspergillus galactomannan assays caused by different antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202412

Homogenisation of cystic fibrosis sputum by sonication — An essential step for Aspergillus PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202412

Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FTHORAXJNL-2012-202412

10.1136/THORAXJNL-2012-202412

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

23513028

1 reference

21 December 2017